ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a global full-service contract research organization, will be in attendance at upcoming April meetings in Europe and North America. PSI staff will be available for consultations and discussions regarding on-time planning and delivery of global clinical trials. Following PSI’s recent nomination for top performing global CRO as selected by investigative sites, PSI staff extend their gratitude to the investigative teams around the world and look forward to connecting at DIA and beyond.
27th Annual DIA EuroMeeting, April 13-15. The event is being held at the Palais des Congrès in Paris, France.
2nd Annual Clinical Operations in Oncology West Coast, April 15-16 at the Westin San Francisco Airport, Burlingame, CA.
Partnerships in Clinical Trials, April 22-24 at the Boston Convention Center, Boston, MA.
About PSI CRO AG: PSI is a Swiss-based privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com